Target intelligence / Profile preview

Bacterial fimbria

Molecular classification
Other (surface appendage), Adhesion molecule/protein complex
01

Overview

Fimbriae are short, hair-like proteinaceous appendages found on the surface of many Gram-negative bacteria and some Gram-positive species[1][2]. They consist primarily of polymerized pilin subunits arranged helically into slender tubes extending from the cytoplasmic membrane through the cell wall[1]. Each bacterium may express hundreds or thousands of these structures simultaneously. The primary function of bacterial fimriae is **adhesion**, enabling bacteria to attach firmly to environmental surfaces—including epithelial cells—resist mechanical flushing forces such as urine flow or mucociliary clearance, and establish infection foci within hosts[3][5]. At their tips reside specialized proteins called *adhesins*, which recognize specific glycoprotein/glycolipid receptors on host cells with high specificity ("lock-and-key" interaction)[5]. Fimbral-mediated adherence is essential for colonization during infection by pathogens such as *Escherichia coli* (urinary tract infections), *Neisseria gonorrhoeae* (gonorrhea), and *Neisseria meningitidis* (meningitis)[3][5]. Because they play critical roles in virulence but are not required for basic survival outside hosts, they represent attractive—but challenging—targets for anti-infective strategies focused on preventing initial colonization rather than killing bacteria outright.

Other names
FimbriaFimbrial adhesinAttachment pilusShort attachment piliColonization factor
02

Mechanism of action

Drugs/vaccines targeting bacterial fimbriae typically act by: - Blocking adhesion between bacteria and host cell receptors - Inducing immune responses against adhesive proteins

03

Biological functions

Adherence/adhesion to host cells and surfacesColonization of host tissuesVirulence factor in pathogenesis/infection
04

Disease associations

Infection (especially urinary tract infections, gonorrhea, meningitis)
05

Safety considerations

Antigenic variation among different bacteria/fimbral types complicates vaccine/drug designOff-target effects on commensal flora expressing similar structures
06

Interacting drugs

No approved drugs directly target all bacterial fimbriae

2 more in the full profile.

07

Biomarkers

Expression of specific types of bacterial fimbria can serve as biomarkers for pathogenic strains (e.g., detection of P-fimbria in uropathogenic E. coli)

Beyond the preview

Go deeper on Bacterial fimbria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial fimbria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call